Balance Sheet Data

ACADIA Pharmaceuticals Inc. (ACAD)

$15.11

+0.11 (+0.73%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 341.34473.52697.43631.96520.711,299.921,854.232,644.923,772.785,381.57
Total Cash (%)
Account Receivables 18.4327.7937.8750.2865.3487.32124.56177.67253.43361.50
Account Receivables (%)
Inventories 5.254.076.349.687.8816.1723.0732.9146.9466.96
Inventories (%)
Accounts Payable 8.793.177.228.496.8819.2327.4339.1355.8179.61
Accounts Payable (%)
Capital Expenditure -0.81-2.15-1.13-7.59-1.12-5.38-7.67-10.94-15.60-22.25
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.